Close Menu

NEW YORK (GenomeWeb) – Insurers that want to use genetic testing to determine members' eligibility for insurance coverage should publish data showing these tests are scientifically valid and be transparent about conflicts of interest, according to a resolution approved by the American Dental Association's House of Delegates.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.